Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line
Wei Yang, Jianhua Liu, Lin Hou, et al.
Life Sciences (2020) Vol. 265, pp. 118796-118796
Closed Access | Times Cited: 25

Showing 25 citing articles:

Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology
Snehlata Yadav, Ajay Sharma, Gulzar Ahmad Nayik, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 67
Therapeutic application of natural products: NAD+ metabolism as potential target
Guo Chen, Qingxia Huang, Yisa Wang, et al.
Phytomedicine (2023) Vol. 114, pp. 154768-154768
Closed Access | Times Cited: 44
Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches
Qiang Sun, Ting Gong, Maolun Liu, et al.
Phytomedicine (2021) Vol. 94, pp. 153805-153805
Closed Access | Times Cited: 95
Programmed cell death, redox imbalance, and cancer therapeutics
Xiaofeng Dai, Danjun Wang, Jianying Zhang
APOPTOSIS (2021) Vol. 26, Iss. 7-8, pp. 385-414
Closed Access | Times Cited: 46
Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities
Hengdong Qu, Junli Liu, Di Zhang, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1930-1930
Open Access | Times Cited: 16
From natural herbal wisdom to nano innovation: Revolutionizing tumor treatment through metabolic reprogramming
Zhengguang Zhang, Haitao Wu, Min Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189263-189263
Closed Access
Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells
Junli Zhang, Ling Shang, Wendi Jiang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7904-7918
Open Access | Times Cited: 26
Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy
Wenxia Li, Hangjie Fu, Liuyuan Fang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Inhibition of PKM2 suppresses osteoclastogenesis and alleviates bone loss in mouse periodontitis
Feng Li, Xinyuan Liu, Mingjuan Li, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111658-111658
Closed Access | Times Cited: 4
Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics
Ali H. El‐Far, Soad K. Al Jaouni, Xiaotao Li, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 8, pp. 3181-3201
Closed Access | Times Cited: 19
ROS in hepatocellular carcinoma: What we know
Lin Xing, Yu-Ting Tang, Lu Li, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 744, pp. 109699-109699
Closed Access | Times Cited: 11
Docetaxel suppressed cell proliferation through Smad3/HIF-1α-mediated glycolysis in prostate cancer cells
Junming Peng, Zhijun He, Yeqing Yuan, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Aerobic glycolysis of vascular endothelial cells: a novel perspective in cancer therapy
Shenhao Xu, Jiahao Liao, Bing Liu, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 2
GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation
Francesco Canonico, Daniela Pedicino, Anna Severino, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 16, pp. 2653-2662
Open Access | Times Cited: 11
Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications
Peng Chen, Liang Lou, Bigyan Sharma, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 20, pp. 2955-2973
Closed Access | Times Cited: 5
Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: A review
Shuangxia Zhang, Zhang‐Xiu Liao, Shubo Li, et al.
Medicine (2023) Vol. 102, Iss. 42, pp. e35571-e35571
Open Access | Times Cited: 4
Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma
Feng Tian, Daxia Cai
Gene (2021) Vol. 807, pp. 145964-145964
Closed Access | Times Cited: 8
Shikonin impairs mitochondrial activity to selectively target leukemia cells
Alessia Roma, Matthew Tcheng, Nawaz Ahmed, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 3, pp. 100300-100300
Open Access | Times Cited: 5
Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species
Qi Ke, Jiayi Li, Yang Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines
Safia Safa-Tahar-Henni, Karen L. Martinez, Verena Gress, et al.
Leukemia (2024)
Open Access
Shikonin Induces Autophagy and Apoptosis in Esophageal Cancer EC9706 Cells by Regulating the AMPK/mTOR/ULK Axis
Junli Zhang, Jiayi Guo, Biao Gu, et al.
Analytical Cellular Pathology (2024) Vol. 2024, Iss. 1
Open Access
Bioavailability and Pharmacological Properties of Shikonin‐ A Phytocompound from Lithospermum Erythrorhizon
Stuti Biswal, Bijesh K. Biswal
ChemistrySelect (2024) Vol. 9, Iss. 45
Closed Access
Comprehensive proteomic analysis of the main liver and attached liver of <i>Glyptosternum maculatum</i> on the basis of data-independent mass spectrometry acquisition
G. Zhang, Zen-Bo Mou, H. Wang, et al.
Journal of Animal and Feed Sciences (2022) Vol. 32, Iss. 1, pp. 85-118
Open Access | Times Cited: 1
NQ-18/19 Induces Apoptosis and Autophagy in Non-Small Cell Lung Cancer by Targeting PI3K/AKT and MAPK Signaling Pathways
Lin Ma, Jiahui Zhang, Yuan Rui, et al.
(2023)
Closed Access
Murine double minute gene 2 (MDM2) promoted hepatocellular carcinoma (HCC) cell growth by targeting fructose-1,6-bisphosphatase (FBP1) for degradation
Yao Xu, Bin Wu, Jing Yang, et al.
Biocell (2022) Vol. 46, Iss. 6, pp. 1483-1491
Open Access
Page 1

Scroll to top